DPYD Testing: Time to Put Patient Safety First

J Clin Oncol. 2023 May 20;41(15):2701-2705. doi: 10.1200/JCO.22.02364. Epub 2023 Feb 23.
No abstract available

MeSH terms

  • Capecitabine
  • Dihydrouracil Dehydrogenase (NADP) / genetics
  • Fluorouracil*
  • Genotype
  • Humans
  • Patient Safety*

Substances

  • Fluorouracil
  • Capecitabine
  • Dihydrouracil Dehydrogenase (NADP)